Gene · 53369
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Associations between the lipid profile and the development of hypertension in young individuals - the preliminary study. | Arch Med Sci | 2022 | 35154522 | PubTator, text mining | PubMed |
| Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins. | J Clin Lipidol | 2022 | 35148982 | PubTator, text mining | PubMed |
| Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients. | NPJ Parkinsons Dis | 2022 | 35136088 | PubTator, text mining | PubMed |
| Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma. | J Lipid Res | 2022 | 35016907 | PubTator, text mining | PubMed |
| HDL functionality in type 1 and type 2 diabetes: new insights. | Curr Opin Endocrinol Diabetes Obes | 2022 | 34980868 | PubTator, text mining | PubMed |
| Lipoprotein subfractions in patients with sarcopenia and their relevance to skeletal muscle mass and function. | Exp Gerontol | 2022 | 34954281 | PubTator, text mining | PubMed |
| Deoxysphingolipids Upregulate MMP-1, Downregulate TIMP-1, and Induce Cytotoxicity in Human Schwann Cells. | Neuromolecular Med | 2022 | 34853975 | PubTator, text mining | PubMed |
| Impact of Replacement of Individual Dietary SFAs on Circulating Lipids and Other Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Humans. | Adv Nutr | 2022 | 34849532 | PubTator, text mining | PubMed |
| The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function. | Biochim Biophys Acta Mol Cell Biol Lipids | 2022 | 34800735 | PubTator, text mining | PubMed |
| Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism. | Bosn J Basic Med Sci | 2022 | 34784265 | PubTator, text mining | PubMed |
| Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high-density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus. | Biofactors | 2022 | 34741558 | PubTator, text mining | PubMed |
| Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia. | Br J Nutr | 2022 | 34511137 | PubTator, text mining | PubMed |
| Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes. | Cardiovasc Drugs Ther | 2022 | 33740174 | PubTator, text mining | PubMed |
| Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial. | Front Nutr | 2021 | 35281761 | PubTator, text mining | PubMed |
| Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD). | Int J Hepatol | 2021 | 34976412 | PubTator, text mining | PubMed |
| Baseline Insulin Resistance Is a Determinant of the Small, Dense Low-Density Lipoprotein Response to Diets Differing in Saturated Fat, Protein, and Carbohydrate Contents. | Nutrients | 2021 | 34959879 | PubTator, text mining | PubMed |
| Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials. | J Clin Med | 2021 | 34945193 | PubTator, text mining | PubMed |
| The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism. | Biomedicines | 2021 | 34944655 | PubTator, text mining | PubMed |
| Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury. | Cells | 2021 | 34943838 | PubTator, text mining | PubMed |
| Genomic Variants and Multilevel Regulation of ABCA1, ABCG1, and SCARB1 Expression in Atherogenesis. | J Cardiovasc Dev Dis | 2021 | 34940525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53369/papers?page=11